Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
from H.C. Wainwright issued a price target of $135.00 for NKTR on 2025-12-16 17:48:54.The adjusted price target was set to $135.00.At the time of the announcement, NKTR...
December 16, 2025 NKTR -6.70%
Jay Olson from Oppenheimer issued a price target of $115.00 for NKTR on 2025-12-16 16:08:23.The adjusted price target was set to $115.00.At the time of the announcement, NKTR...
December 16, 2025 NKTR -6.70%
from Wedbush issued a price target of $5.50 for GBIO on 2025-12-16 14:09:10.The adjusted price target was set to $5.50.At the time of the announcement, GBIO was...
December 16, 2025 GBIO -0.74%
Mohit Bansal from Wells Fargo issued a price target of $8.00 for MIST on 2025-12-16 11:45:33.The adjusted price target was set to $8.00.At the time of the announcement,
December 16, 2025 MIST -4.69%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| PETS PetMed Express, Inc. | 3.94
37.13% | ||||||||||||||||||
| ALDX Aldeyra Therapeutics, Inc | 5.29
32.46% | ||||||||||||||||||
| CLNNW Clene Inc. | 0.01
30.43% | ||||||||||||||||||
| VRA Vera Bradley, Inc. | 2.18
19.13% | ||||||||||||||||||
| BNR Burning Rock Biotech Limi | 18.58
17.91% | ||||||||||||||||||
| SKIL Skillsoft Corp. | 6.66
17.37% | ||||||||||||||||||
| VOR Vor Biopharma Inc. | 15.78
16.80% | ||||||||||||||||||
| VRCA Verrica Pharmaceuticals I | 8.65
14.42% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -0.56%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -2.38%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 2.52%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 0.61%